113. Best of: Recent Drug Approvals (vol. 1)! - Upadacitinib for AD - Tralokinumab for AD - Baricitinib for AA - Deucravacitinib for psoriasis - Spinosad for scabies

Dermasphere - The Dermatology Podcast - A podcast by Luke Johnson - Mondays

Best of: Recent Drug Approvals (vol. 1) - Upadacitinib for AD (from episode 59) - Tralokinumab for AD (from episode 73) - Baricitinib for AA (from episode 87) - Deucravacitinib for psoriasis (from episode 93) - Spinosad for scabies (from episode 103) Check out our video content on YouTube: Dermasphere Podcast - YouTube - and VuMedi!: https://www.vumedi.com/channel/dermasphere/ The University of Utah's Dermatology ECHO: ⁠⁠https://physicians.utah.edu/echo/dermatology-primarycare - ⁠⁠Connect with us! - Web: ⁠https://dermaspherepodcast.com/⁠ - Twitter: @DermaspherePC - Instagram: dermaspherepodcast - Facebook: https://www.facebook.com/DermaspherePodcast/ - Check out Luke and Michelle’s other podcast, SkinCast! ⁠https://healthcare.utah.edu/dermatology/skincast/⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at: - ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge) - ⁠https://www.levelex.com/games/top-derm⁠ (A free dermatology game to learn more dermatology!)

Visit the podcast's native language site